Catalyst
Slingshot members are tracking this event:
Lexicon Pharma (LXRX) Expects Commercial Launch of Telotristat Ethyl in Late Q1 for Patients with Carcinoid Syndrome
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| LXRX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 03, 2017
Occurred Source:
http://www.lexpharma.com/media-center/news/627-lexicon-pharmaceuticals-provides-clinical-pipeline-update-and-reports-2016-fourth-quarter-and-full-year-financial-results
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Telotristat Ethyl, Carcinoid Syndrome
